Table 4.

Disease distribution by average duration of exposure and latency in years.

	Average exposure duration in years	1–10 years	11–20 years	21–30 years	31–40 years	41–50 years	51–ω years	Total
Average latency duration	10–30	4	7	7	3	-	-	21 (17.2%)	Asbestosis
	31–50	6	14	39	13	3	1	76 (62.3%)
	51–60	1	3	3	9	2	-	18 (14.7%)
	61–ω	-	-	3	3	1	-	7 (5.7%)
	Total	11 (9%)	24 (19.7%)	52 (42.6%)	28 (22.9%)	6 (4.9%)	1 (0.8%)	122 (100%)
	10–30	2	10	28	9	2	-	51 (30.5%)	Pleural plaques
	31–50	5	14	42	20	7	-	88 (52.6%)
	51–60	2	3	5	11	1	-	22 (13.2%)
	61–ω	1	1	3	1	-	-	6 (3.6%)
	Total	10 (6%)	28 (16.7%)	78 (46.4%)	41 (24.4%)	10(6%)	-	167 (100%)
	10–30	1	6	4	1	-	-	12 (17.4%)	MPM
	31–50	2	5	26	11	1	1	46 (66.7%)
	51–60	-	1	1	4	3	-	9 (13%)
	61–ω	-	-	1	1	-	-	2 (2.9%)
	Total	3 (4.3%)	12 (17.4%)	32 (46.4%)	17 (24.6%)	4 (5.8%)	1 (1.4%)	69 (100%)
	10–30	1	3	5	-	-	-	9 (29%)	MTVT
	31–50	2	4	11	1	2	-	20 (64.5%)
	51–60	-	1	1	-	-	-	2 (6.4%)
	61–ω	-	-	-	-	-	-	-
	Total	3 (9.7%)	8 (25.8%)	17 (54.8%)	1 (3.2%)	2 (6.4%)	-	31 (100%)

MPM, pleural malignant mesothelioma; MTVT, mesothelioma tunica vaginalis testis.